Browse Data and Analysis
Filter
Search Data and Analysis
- 2 results found
- (-) November 2024
- (-) Germany
- (-) Tunisia
- Clear all
Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Genetically-engineered (GE) products are highly politicized in Germany. As the EU takes gradual steps towards potentially liberalizing NGTs, German public debate is beginning to shift from a general rejection of GE towards discussion regarding possible liberalization of New Genomic Techniques (NGTs).